NCT01927510

Brief Summary

Patients in the intensive care unit (ICU) traditionally receive bed rest as part of their care. They develop muscle weaknesses even after only a few days of mechanical ventilation that may prolong their time in ICU and in hospital, delay functional recovery and delay their return home and to work. Weakness may be avoided with simple strategies of early exercise in ICU. This pilot study aims to test the hypothesis that early mobilisation may improve functional recovery in this patient group and gather pilot data to support a larger randomised trial across Australia and New Zealand.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Aug 2013

Geographic Reach
2 countries

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

August 15, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 22, 2013

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

August 22, 2018

Status Verified

June 1, 2015

Enrollment Period

1.3 years

First QC Date

August 15, 2013

Last Update Submit

August 21, 2018

Conditions

Keywords

Early mobilization, rehabilitation, intensive care

Outcome Measures

Primary Outcomes (6)

  • Highest daily level of activity measured using the ICU mobillity scale

    ICU Mobility Scale - ranges from 0 (Nothing/Lying in Bed) to 10 (Walking Independently without a Gait Aid)

    Duration of ICU stay (an average of 10 days)

  • Total Duration of Active Mobilisation

    Radomisation to removal of invasive ventilation (an average of 7 days)

  • Mean (or Median) Daily Duration of Active Mobilisation

    Measured in minutes, any mobilisation activity where the patient can use their own muscle force to assist the movement.

    Randomisation to removal of invasive ventilation (daily for an average of 7 days)

  • Total Duration of Active Mobilisation

    Pt will be free of Mechanical Ventilation, Vasopressors and Continuous Renal Replacement Therapy for 24 Hours

    Randomisation to ICU discharge, an average of 10 days

  • Mean (or Median) Daily Duration of Active Mobilisation

    Pt will be free of Mechanical Ventilation, Vasopressors and Continuous Renal Replacement Therapy for 24 Hours (approximately 10 days)

    Randomisation to Time of Final Listing for Ward Discharge, an average of 10 days

  • Proportion of Patients achieving each Category of Highest Level of Mobilisation on Each Day

    Measured using the ICU mobility scale (0-10)

    Randomisation to Extubation, an average of 7 days

Secondary Outcomes (6)

  • Physical Function

    At 6 months from randomisation

  • Recruitment Rates

    Entirety of Study

  • Staff Utilisation Costs

    ICU admission (approximately 10 days)

  • Ventilator and IC free days at Day 28

    Randomisation to Day 28

  • Health related quality of life

    6 Months after ICU admission

  • +1 more secondary outcomes

Study Arms (2)

early mobilisation

EXPERIMENTAL

intervention of early mobilisation

Behavioral: Early mobilisation

Control

NO INTERVENTION

Standard care

Interventions

Also known as: Rehabilitation
early mobilisation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults \> or + to 18 years old admitted to the ICU
  • Invasively ventilated and expected to be ventilated the day after tomorrow
  • Written informed consent from person responsible/ net of kin (or consent as per individual HREC if delayed or telephone consent is acceptable)

You may not qualify if:

  • INSTABILITY A. Cardiovascular
  • Unresolved rhythm disturbance with any bradycardia requiring pharmacological support
  • Any tachycardia with ventricular rate \> 150 beats/min
  • Lactacte \> 4.0 due to inadequate tissue perfusion
  • Any external mechanical cardiovascular support (eg. VA ECMO or intra-aortic balloon pump)
  • Norad \> 0.2mcg/kg/min (or unit equivalent) or any dose of norad between 0.1 and 0.2mcg/kg/min with more than a 25% increase in last 6 hours
  • Cardiac index \< 2.0L/min/m\^2
  • B. Respiratory
  • FiO2 \> 0.6
  • PEEP \> 15
  • Requirement for hypoxaemic rescue interventions eg. NO, prone, ECMO, prostacyclin, HFOV
  • RR \> 45
  • Proven or suspected actue brain injury such as stroke, sub-arachnoid haemorrhage, encephalitis, or moderate to severe traumatic brain injury
  • Proven or suspected actue spinal cord injury
  • Proven or suspected Guillain-Barre Syndrome
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

The Austin Hospital

Heidelberg, Victoria, 3084, Australia

Location

The Alfred Hospital

Melbourne, Victoria, 3004, Australia

Location

Fremantle Hospital

Fremantle, Western Australia, 6160, Australia

Location

Auckland CIty Hospital CVICU

Grafton, Auckland, 1023, New Zealand

Location

Wellington Hospital

Newtown, Wellington Region, 6021, New Zealand

Location

Related Publications (1)

  • Hodgson CL, Bailey M, Bellomo R, Berney S, Buhr H, Denehy L, Gabbe B, Harrold M, Higgins A, Iwashyna TJ, Papworth R, Parke R, Patman S, Presneill J, Saxena M, Skinner E, Tipping C, Young P, Webb S; Trial of Early Activity and Mobilization Study Investigators. A Binational Multicenter Pilot Feasibility Randomized Controlled Trial of Early Goal-Directed Mobilization in the ICU. Crit Care Med. 2016 Jun;44(6):1145-52. doi: 10.1097/CCM.0000000000001643.

    PMID: 26968024BACKGROUND

MeSH Terms

Conditions

Critical Illness

Interventions

Rehabilitation

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Carol L Hodgson, PhD

    Australian and New Zealand Intensive Care Research Centre

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 15, 2013

First Posted

August 22, 2013

Study Start

August 1, 2013

Primary Completion

November 1, 2014

Study Completion

February 1, 2015

Last Updated

August 22, 2018

Record last verified: 2015-06

Locations